Chandra Vargeese
Chief Tech/Sci/R&D Officer bei WAVE LIFE SCIENCES LTD.
Vermögen: 594 455 $ am 31.03.2024
Profil
Chandra Vargeese is currently the Chief Technology Officer at Wave Life Sciences Ltd.
since 2020.
Previously, Chandra held positions at Merck & Co., Inc. as Senior Director, Head-RNA Chemistry & Delivery from 2007 to 2008, at NeXstar Pharmaceuticals, Inc. as Associate Director-Chemistry from 1993 to 1998, at Novartis AG as Executive Director-Chemistry & Delivery from 2008 to 2014, and at Sirna Therapeutics, Inc. as Vice President-Chemistry from 1998 to 2006.
Chandra obtained a doctorate degree from the Indian Institute of Science in 1988.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
WAVE LIFE SCIENCES LTD.
0,08% | 05.02.2024 | 96 346 ( 0,08% ) | 594 455 $ | 31.03.2024 |
Aktive Positionen von Chandra Vargeese
| Unternehmen | Position | Beginn |
|---|---|---|
| WAVE LIFE SCIENCES LTD. | Chief Tech/Sci/R&D Officer | 01.06.2020 |
Ehemalige bekannte Positionen von Chandra Vargeese
| Unternehmen | Position | Ende |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01.06.2014 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01.08.2008 |
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01.12.2006 |
NeXstar Pharmaceuticals, Inc.
 NeXstar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeXstar Pharmaceuticals, Inc. was a commercial biopharmaceutical company engaged in the discovery, development, manufacture and marketing of proprietary pharmaceutical products to treat life-threatening and other serious diseases. The firm was located in Boulder, CO. | Corporate Officer/Principal | 01.01.1998 |
Ausbildung von Chandra Vargeese
| Indian Institute of Science | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| WAVE LIFE SCIENCES LTD. | Health Technology |
| NOVARTIS AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
NeXstar Pharmaceuticals, Inc.
NeXstar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeXstar Pharmaceuticals, Inc. was a commercial biopharmaceutical company engaged in the discovery, development, manufacture and marketing of proprietary pharmaceutical products to treat life-threatening and other serious diseases. The firm was located in Boulder, CO. | Health Technology |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Commercial Services |
